Big Cypress Acquisition (BCYP) Stock Price, News & Analysis

Company Overview

Big Cypress Acquisition Corp. does not have significant operations. The company intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or similar business combination. It primarily focuses in the life science sector. The company was incorporated in 2020 and is based in Miami Beach, Florida.

Key Stats

• Today's Range: $8.21 to $12.90
• 50-Day Range: $8.44 to $8.44
• 52-Week Range: $8.21 to $12.90
• Volume: 15.34 million shs
• Average Volume: 160,982 shs
• Market Capitalization: $124.84 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BCYP Stock Analysis - Frequently Asked Questions

How have BCYP shares performed this year?

Big Cypress Acquisition's stock was trading at $8.44 on January 1st, 2025. Since then, BCYP stock has increased by 0.0% and is now trading at $8.44.
View the best growth stocks for 2025 here.

How were Big Cypress Acquisition's earnings last quarter?

Big Cypress Acquisition Corp. (OTCMKTS:BCYP) issued its earnings results on Tuesday, November, 11th. The technology company reported ($0.01) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.01). The technology company had revenue of $0.31 million for the quarter, compared to analyst estimates of $0.21 million.

How do I buy shares of Big Cypress Acquisition?

Shares of BCYP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Big Cypress Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Big Cypress Acquisition investors own include FuelCell Energy (FCEL), Onconova Therapeutics (ONTX), Co-Diagnostics (CODX), iBio (IBIO), Tonix Pharmaceuticals (TNXP), Vaxart (VXRT) and Adamis Pharmaceuticals (ADMP).

Company Calendar

• Last Earnings: 11/11/2014
• Today: 6/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biological Products, Except Diagnostic
• Sub-Industry: Personal Services
• Current Symbol: OTCMKTS:BCYP
• CIK: 1399587
• Web: www.bluecalypso.com
• Phone: 305-204-3338
• Fax: N/A
• Employees: 17
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 6.13
• Quick Ratio: 6.13

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 14,792,000
• Free Float: N/A
• Market Cap: $124.84 million
• Optionable: Not Optionable
• Beta: N/A